Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Medchemcomm|August 16, 2018
5-Methyl-N-(8-(5,6,7,8-tetrahydroacridin-9-ylamino)octyl)-5H-indolo[2,3-b]quinolin-11-amine: a highly potent human cholinesterase inhibitorLi Wang, Ignacio Moraleda, Isabel Iriepa, et al.
RSC Medicinal Chemistry|July 5, 2021
Studies on the affinity of 6-[(n-(cyclo)aminoalkyl)oxy]-4H-chromen-4-ones for sigma 1/2 receptorsWinnie Deuther-Conrad, Daniel Diez-Iriepa, Isabel Iriepa, et al.
Future Medicinal Chemistry|June 11, 2015
Pyranopyrazolotacrines as nonneurotoxic, Aβ-anti-aggregating and neuroprotective agents for Alzheimer's diseaseMourad Chioua, Javier Pérez-Peña, Nuria García-Font, et al.
Molecules (Basel, Switzerland)|August 1, 2018
Exploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer's DiseaseAngela Rampa, Manuela Bartolini, Letizia Pruccoli, et al.
Molecules (Basel, Switzerland)|July 17, 2020
Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer's Disease TherapyLazhar Zribi, Irene Pachòn-Angona, Òscar M Bautista-Aguilera, et al.
Bioorganic Chemistry|August 26, 2019
Multi-target 1,4-dihydropyridines showing calcium channel blockade and antioxidant capacity for Alzheimer's disease therapyRim Malek, Maciej Maj, Artur Wnorowski, et al.
The Journal of Organic Chemistry|May 3, 2023
Straightforward Synthesis of Bis[(trifluoromethyl)sulfonyl]ethylated Isocoumarins from 2-EthynylbenzoatesA Sonia Petcu, Carlos Lázaro-Milla, F Javier Rodríguez, et al.
Journal of Proteome Research|October 29, 2020
Molecular Basis of SARS-CoV-2 Infection and Rational Design of Potential Antiviral Agents: Modeling and Simulation ApproachesAntonio Francés-Monerris, Cécilia Hognon, Tom Miclot, et al.
ACS Chemical Neuroscience|April 4, 2019
Novel Quinolylnitrones Combining Neuroprotective and Antioxidant PropertiesMourad Chioua, Manuel Salgado-Ramos, Daniel Diez-Iriepa, et al.
European Journal of Medicinal Chemistry|April 30, 2016
Potent anticholinesterasic and neuroprotective pyranotacrines as inhibitors of beta-amyloid aggregation, oxidative stress and tau-phosphorylation for Alzheimer's diseaseNuria García-Font, Hasna Hayour, Ali Belfaitah, et al.
Pageof 7